UPDATED May 09, 2024
Discover U.S. Pharmaceuticals & Biotech Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
LIFE | US$1.72 | 7.5% | -26.5% | US$114.8m | US$22.60 | PS198.7x | E67.3% | n/a | ||
AKBA | US$1.33 | 2.3% | 25.5% | US$293.1m | US$5.00 | PS1.5x | E67.2% | n/a | ||
HROW | US$10.29 | -3.3% | -62.0% | US$364.9m | US$25.65 | PS2.8x | E67.2% | n/a | ||
ZYNE | US$1.30 | 4.0% | 96.1% | US$65.6m | US$1.26 | PB2.3x | E67.2% | n/a | ||
EXAS | US$54.15 | -10.6% | -30.6% | US$10.9b | US$88.43 | PS3.9x | E66.9% | n/a | ||
SNCE | US$5.75 | 0.3% | 30.9% | US$34.7m | US$13.83 | PB0.7x | E66.7% | n/a | ||
BPMC | US$108.34 | 1.3% | 102.8% | US$6.8b | US$118.13 | PS24x | E66.4% | n/a | ||
EOLS | US$13.13 | -0.7% | 27.5% | US$830.2m | US$22.29 | PS3.7x | E66.4% | n/a | ||
GBT | US$68.49 | 0.6% | 169.5% | US$4.6b | US$68.50 | PS19.7x | E66.2% | n/a | ||
BCRX | US$5.34 | 19.2% | -36.1% | US$1.1b | US$14.00 | PS3.1x | E66.2% | n/a | ||
CDMO | US$8.14 | -0.7% | -53.9% | US$532.0m | US$12.50 | PS3.8x | E66.1% | n/a | ||
BFRI | US$1.58 | -11.7% | -86.0% | US$7.8m | US$16.00 | PB1.7x | E65.8% | n/a | ||
ZVRA | US$5.03 | 5.9% | 18.1% | US$215.9m | US$19.00 | PS7.6x | E65.7% | n/a | ||
MIRM | US$25.83 | 0.9% | -1.5% | US$1.2b | US$48.36 | PS5.4x | E65.7% | n/a | ||
XERS | US$1.88 | 1.1% | -35.6% | US$274.3m | US$4.90 | PS1.6x | E65.6% | n/a | ||
ARCT | US$26.79 | 1.0% | -17.2% | US$732.8m | US$67.89 | PS5.8x | E65.1% | n/a | ||
AXSM | US$73.68 | -0.7% | -5.5% | US$3.6b | US$123.56 | PS13.9x | E65.1% | n/a | ||
IVVD | US$2.42 | 0% | 68.1% | US$301.6m | US$9.38 | PB1.6x | E65.1% | n/a | ||
ASND | US$133.13 | -5.6% | 38.8% | US$7.7b | US$180.08 | PS26.4x | E65.0% | n/a | ||
PTN | US$2.35 | 14.6% | 5.4% | US$33.1m | US$9.33 | PS5.3x | E64.9% | n/a | ||
GERN | US$3.88 | -1.3% | 25.2% | US$2.3b | US$6.07 | PS4425.7x | E64.9% | n/a | ||
EVAX | US$3.77 | -3.1% | -75.8% | US$20.9m | US$11.75 | PS279.4x | E64.7% | n/a | ||
MDGL | US$206.92 | -4.2% | -28.2% | US$4.4b | US$364.29 | PB5.2x | E64.3% | n/a | ||
ALNY | US$151.37 | 0.7% | -26.6% | US$19.3b | US$220.38 | PS9.6x | E64.2% | n/a |